Track antibiotic levels in ICU patients with sepsis
Part of Infections clinical trials.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be currently in an intensive care unit (ICU).
- You must be receiving an antibiotic to treat sepsis or septic shock.
- You (or a family member) must be willing to participate in the study.
- You should not be taking antibiotics just to prevent infection before it starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at treating ICU patients with sepsis (a serious body-wide infection) using antibiotics. It may help doctors understand which antibiotic approach works best for critically ill patients.
This study monitors the amount of certain antibiotics in the blood of patients with acute brain injury in the intensive care unit. It aims to make sure the antibiotics are at the right level to fight infection, especially in patients whose kidneys are clearing drugs faster than normal.
This study measures levels of beta-lactam antibiotics in the blood of ICU patients with sepsis to ensure the right dose is given. It aims to improve treatment by checking if antibiotic levels are effective without being too high or too low.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
Hear when a new Intensive Care Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.